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Abstract
Background: Complications of hypertension are particularly common in people of African descent but previous
reports had suggested rarity of hypertensive retinopathy in black Africans. We evaluated retinal changes among
Nigerian hypertensive patients and determined their relationship with renal function.
Methods: Consecutive Hypertensive patients who were ≥18 years were selected for the study. Socio-demographic
characteristics, anthropometric parameters and blood pressure were measured. All patients had ophthalmoscopic
examination and retinal changes were graded according to Keith-Wegener’s classification. Blood samples were
taken for blood urea nitrogen, lipids and C-reactive protein; and urine was collected for creatinine and microalbuminuria.
Serum creatinine was determined using modified Jaffe method and estimated glomerular filtration (eGFR) was
calculated using MDRD equation: 186 × (Creatinine/88.4)-1.154 × (Age)-0.203 × (0.742 if female) × (1.210 if black).
Results: Of the 240 patients studied, 187 (78 %) had one form of retinopathy or the other. While 85 (35.4 %) patients
had grade 1 retinopathy, 87 (36.3 %) had grade 2, 13 (5.4 %) had grade 3 and 2 (0.83 %) had grade 4 respectively.
Comparison of patients with and without retinopathy showed that, the former were older (p = 0.001) and had longer
duration of hypertension (p = 0.001). Similarly, hypertensive patients with retinopathy had higher total cholesterol and
low density lipoprotein cholesterol (p = 0.017, p = 0.041 respectively). However, eGFR was lower in individuals with
retinopathy (46.2 ml/min/1.73) than those with normal retinal (55.9 ml/min/1.73) findings, p = 0.019. Multi-variable
adjusted odds ratios showed increased probability of retinopathy with age (odds ratio-1.08, p = 0.001) and body mass
index (odds ratio-1.20, p = 0.013).
Conclusions: Hypertensive retinopathy is a common clinical finding among hypertensive Nigerians and may occur pari
passu with renal damage as consequences of long standing hypertension.
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Background
Systemic hypertension is a major public health concern
that affects more than one billion people world-wide [1].
The prevalence of hypertension is known to be high in
black Africans in whom the disease presents early and
runs a rapid course [2]. Retinal micro-vascular abnor-
malities such as arterial narrowing, arteriovenous nick-
ing and retinopathy reflect the vascular damage from
hypertension [3]. These retinal changes appear to be ir-
reversible long term markers of hypertension and may
relate to current and past blood pressures. The presence
of retinopathy indicates that a person’s hypertension has
progressed to a severe stage with associated target organ
damage [4]. Blood vessel damage in the eye as a result of
hypertension has been tracked with similar changes in
the brain and has been found to be a potential risk of
stroke and death, independent of known risk factors [5].
The presence of retinopathy may be an indication for
initiating antihypertensive treatment, even in people
with stage 1 hypertension (blood pressure, 140 to 159/90
to 99 mm Hg) who have no other evidence of target-
organ damage [6]. Although, an earlier study among
continental Africans [7] showed hypertensive retinopathy
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to be rare, evidence is accumulating to suggest that
the incidence of hypertensive retinopathy is higher
among Africans than Caucasians in United States of
America [8, 9]. Blacks are also more likely to develop
hypertension-related complications such as heart failure,
stroke and kidney diseases than Whites. Indeed, the com-
bination of target organ damage (left ventricular hyper-
trophy (LVH) and chronic kidney disease) in patients with
systemic hypertension has been found to exaggerate risk
of cardiovascular events [10]. The involvement of retina in
hypertension is similar to the blood vessel damage in the
kidneys (arteriosclerosis) but whether this occur simultan-
eously in the course of the disease is not very clear. We
therefore evaluated retinal and renal profiles in hyperten-
sive patients in our hospital.
Methods
The study was a descriptive cross sectional evaluation of
retinal morphology and renal function among hyperten-
sive patients that were managed at the Medical Out-
Patient Department (MOPD) of our hospital. Consecutive
hypertensive patients seen at the MOPD were recruited if
they were ≥18 years and gave informed consent. Hyper-
tensive patients, who were diabetic, had sickle cell an-
aemia, had history of glaucoma, pregnant and those with
secondary hypertension were excluded from the study.
Ethical approval was obtained from the Ethics and Re-
search Committee of the University of Ilorin Teaching
hospital, Nigeria. The socio-demographic characteristics
of the participants were obtained and a thorough history
including the duration of hypertension, drug therapy and
compliance was taken. The anthropometric parameters,
blood pressure and other relevant clinical examination
were performed on the patients. Blood pressure was mea-
sured at the left arm in a comfortable sitting position after
about 10 min rest using standard mercury sphygmoman-
ometer (Accoson) with an appropriate cuff. However, if
the blood pressure was equal or greater than 10 mmHg at
the right arm, the latter blood pressure was used as the
blood pressure of the subjects. An average of three mea-
surements was taken as the patient’s blood pressure.
Hypertension was defined according to the JNC VII (BP ≥
140/90 mmHg or anti-hypertensive use) [11]. The intra-
ocular pressure was measured using Perkins applanation
tonometer. All patients had ophthalmoscopic examination
done by one of the ophthalmologists (OVA) on the team
after pupillary dilatation with 0.5 % cyclopentolate eye
drops or 1 % tropicamide and retinal changes compatible
with hypertensive changes were assessed. The severity of
patient’s retinal changes was determined and graded ac-
cording to Keith-Wegener’s classification. When in doubt
the opinion of the second ophthalmologist (JFO, more ex-
perienced) was sort who also intermittent examine sample
of patients for concordance. Blood samples were taken
from each patient for blood urea nitrogen, lipids and C-
reactive protein; and urine was collected for creatinine
and microalbuminuria. Serum Blood urea nitrogen was
determined using Modified Berthelot’s method. Serum
C-reactive protein was determined using Turbilatex
method with high sensitivity and specificity. Serum esti-
mation of high density lipoprotein cholesterol (HDL-c)
and low density lipoprotein cholesterol (LDL-c) were
done using Direct Immunoinhibition method. Serum
Total Cholesterol and Triglycerides were determined
using colorimetric enzymatic method. Urine Microalbumin
was determined using quantitative Turbidimetric Immuno-
assay method. Albumin creatinine ratio (ACR) was calcu-
lated using the formula: Urine Albumin (mg/dL)/Urine
Creatinine (g/dL) = ACR in mg/g ≈Albumin excretion in
mg/day. Serum Creatinine was determined using modified
Jaffe method and eGFR was calculated using MDRD
equation: 186 × (Creat/88.4)-1.154 × (Age)-0.203 × (0.742 if
female) × (1.210 if black). Where unit of eGFR =mL/min/
1.73 m2, serum creatinine = μmol/L and age = years. Serum
Uric Acid was determined using Uricase-PAP method. All
the kits used were manufactured by Agappe Diagnostics
International and supplied by NUMS Diagnostics Nigeria
Ltd. Suleja.
Data analysis
Statistical analysis was performed using the SPSS Version
15 (SPSS Inc, Chicago Illinois, USA 2006 edition) and the
numerical values were presented as mean ± SD. Student t-
test was used to compare means of continuous variables
while chi-square test was used to compare means of pro-
portions. Means of variables of interest in patients with
and without retinopathy; and those with ACR ≤300 mg/g
and >300 mg/g were compared using independent t-test.
Relationship between retinopathy and other variables of
interest were determined by Spearman’s Rank correlation
method. Those variables that have no significant correla-
tions with retinopathy were excluded from analysis and
the strength of association of each of the remaining vari-
ables was assessed using partial correlation statistics. Bin-
ary logistic regression was used to determine predictors of
retinopathy and the products were expressed as odd ratio
with 95 % confident interval. A statistically significant as-
sociation was set at P < 0.05.
Results
Two hundred and forty hypertensive patients comprising
of 160 (66.7 %) women and 80 (33.3 %) men were studied
with mean age of 58.9 ± 12.1 years. Baseline clinical and
biochemical characteristics of the patients are shown in
Table 1. The mean BMI in the study participants was
26.6 ± 5.8 kg/m2 which is in the over-weight category. The
mean total cholesterol was 5.9 ± 1.5 mmol/l) while the
mean of HDL-c was 0.9 ± 0.2 mmol/l with coronary artery
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disease risk ratio of 6.6. Median of the eGFR was 49.3
(range 16.5–167.2) mL/min/1.73 m2 which suggests that
significant number of the patients had reduced kidney
function. Similarly, the median of ACR was 93.9 (3.3–
1931.3 mg/g) which also suggests that a good number of
subjects had significant albuminuria.
Figure 1 shows frequency of hypertensive retinopathies
among the participants. One hundred and eighty seven
patients (78 %) had one form of retinopathy or the other.
While 85 (35.4 %) patients had grade 1 retinopathy, 87
(36.3 %) had grade 2, 13 (5.4 %) had grade 3 and 2
(0.83 %) had grade 4 respectively.
When patients with hypertensive retinopathy were
compared with those without retinopathy, the former
were older (p = 0.001) and had longer duration of sys-
temic hypertension (p = 0.001) as shown in Table 2.
Similarly, hypertensive patients with retinopathy have
higher total cholesterol and low density lipoprotein chol-
esterol (p = 0.017, p = 0.041 respectively). On the other
hand, eGFR was lower in individuals with hypertensive
retinopathy (46.2 ml/min/1.73) compared with those
with normal retinal (55.9 ml/min/1.73) findings, p = 0.019.
However, body mass index, blood pressure indices, C-
reactive protein and ACR were similar between patients
with and without retinopathy. Similarly, patients on drug
combinations that included angiotensin converting en-
zyme inhibitors (ACEI) were compared with those on
combinations without ACEI. All parameters compared
were similar except ACR which was lower in those on
ACEI than those not on ACEI. The median of ACR was
77.3 (5.78–1931.3 mg/g) in the former and 104.6 (3.34–
1706.3 mg/g) in the latter. In addition, fewer patients on
ACEI (40.4 %) have grades II-IV retinopathy compared
with those not on ACEI (46.4 %), p = 0.346.
Comparison of patients with ACR ≤300 mg/g against
those who had ACR >300 mg/g is presented in Table 3.
The mean age and duration of hypertension were similar
between the former and the latter. Patients with ACR >
300 mg/g have higher percentage of grade II-IV retinop-
athy, serum uric acid level, total cholesterol, low density
lipoprotein cholesterol, triglycerides and C-reactive pro-
tein than those with ACR ≤ 300 mg/g. On the other
hand, those with ACR > 300 mg/g have lower high dens-
ity lipoprotein cholesterol and eGFR.
Correlates of hypertensive retinopathy are shown in
Table 4. Significant positive correlations were observed
between age, duration of hypertension, body mass index,
total cholesterol, LDL-c and C-reactive protein with retin-
opathy. On the other hand, significant negative correlation
was observed between eGFR and retinopathy. However,
when each of the parameters were assessed individually
(partial correlation), the correlation of total cholesterol
and C-reactive protein with retinopathy were no longer
significant. Binary logistic regression to determine predic-
tors of retinopathy is presented in Table 5. Multi-variable
adjusted odds ratios showed increased probability of
retinopathy with age (odds ratio-1.08, p = 0.001) and body
mass index (odds ratio-1.20, p = 0.013)
Discussion
Systemic hypertension remains the most prevalent car-
diovascular risk factor in indigenous African population
Table 1 Baseline characteristics of the patients (n =240).
Characteristics are presented as mean ± SD, median (range)
Gender (Male/Female), n(%) 80/160 (33.3/66.7)
Age (years) 58.9 ± 12.1
Duration of hypertension (years) 6 (1–37)
Body Mass Index (Kg/m2) 26.6 (5.8)
Systolic Blood pressure (mmHg) 139.86 ± 22.1
Mean Arterial Pressure (mmHg) 104.1 ± 15.0
Pulse Pressure (mmHg) 53.3 ± 16.5
Diastolic Blood Pressure (mmHg) 86.3 ± 13.6
Mean Blood Pressure(mmHg) 97.4 ± 7.9
Waist Circumference (m) 97.4 ± 14.4
Hip Circumference (m) 101.7 ± 14.1
Waist Hip Ratio 0.97 ± 0.11
Uric Acid (mmol/L) 7.5 ± 3.4
Total cholesterol (mmol/L) 5.9 ± 1.5
HDL-Cholesterol (mmol/L) 0.9 (0.2)
Triglyceride (mmol/L) 2.2(0.9)
Low Density Lipoprotein (mmol/L) 2.8 ± 1.0
C-Reactive Protein (g/L) 7.8 ± 2.8
Albumin-Creatinine Ratio (mg/g) 93.9 (3.3–1931.3)
eGFR by MDRD (ml/min/1.73) 49.3 (16.5–167.2)
Fig. 1 shows frequency of hypertensive retinopathies among
the participants
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Table 2 Characteristics of patients with and without retinopathy. Characteristics are presented as mean ± SD, median (range)
Patients with retinopathy (n = 187) Patients without retinopathy (n = 46) P value
Gender (Male/Female), n(%) 80/160 (33.3/66.7)
Age (years) 61.7 ± 10.5 47.2 ± 12.0 0.001
Duration of hypertension (years) 7 (1–37) 4.5 (1–15) 0.001
Body Mass Index (Kg/m2) 26.9 ± 6.0 26.1 ± 4.9 0.422
Systolic Blood pressure (mmHg) 139.5 ± 22.6 141.2 ± 20.8 0.657
Diastolic Blood Pressure (mmHg) 85.8 ± 14.0 88.8 ± 11.8 0.183
Mean Blood Pressure(mmHg) 103.7 ± 15.4 106.2 ± 13.9 0.307
Pulse Pressure (mmHg) 53.8 ± 17.2 52.4 ± 14.2 0.307
Waist Circumference (m) 98.0 ± 14.7 95.6 ± 13.8 0.321
Hip Circumference (m) 102.3 ± 13.9 99.9 ± 14.8 0.308
Waist Hip Ratio 0.97 ± 0.11 0.96 ± 0.13 0.751
Uric Acid (mmol/L) 7.5 ± 3.4 7.5 ± 3.4 0.966
Total cholesterol (mmol/L) 6.1 ± 1.4 5.4 ± 1.7 0.017
HDL-Cholesterol (mmol/L) 0.93 ± 0.21 0.91 ± 0.21 0.593
Triglyceride (mmol/L) 2.3 ± (1.0) 2.0 ± 0.8 0.130
Low Density Lipoprotein (mmol/L) 2.9 ± 1.0 2.5 ± 1.2 0.041
C-Reactive Protein (g/L) 7.9 ± 2.8 7.2 ± 3.1 0.116
Albumin-Creatinine Ratio (mg/g) 93.9(3.9–1931.3) 109.6(3.3–1580) 0.908
eGFR by MDRD (ml/min/1.73) 46.2(16.5–167.2) 55.9(22.5–165.4) 0.019
Table 3 Characteristics of patients with ACR equal or less than 300 mg/g and greater than 300 mg/g Characteristics are presented
as mean ± SD, median (range) or number (%)
Patients with ACR ≤300 mg/g (n = 167) Patients with ACR > 300 mg/g (n = 62) P value
Gender (Male/Female), n(%) 80/160 (33.3/66.7)
Age (years) 58.6 ± 11.4 57.5 ± 12.8 0.548
Duration of hypertension (years) 7.8 ± 7.1 7.8 ± 6.6 0.979
Body Mass Index (Kg/m2) 26.2 ± 5.3 27.9 ± 6.8 0.060
Systolic Blood pressure (mmHg) 139.6 ± 20.8 137.2 ± 20.1 0.470
Diastolic Blood Pressure (mmHg) 86.1 ± 13.2 86.3 ± 12.5 0.895
Mean Blood Pressure(mmHg) 103.9 ± 14.1 103.3 ± 13.7 0.783
Pulse Pressure (mmHg) 53.6 ± 16.6 50.9 ± 15.2 0.309
Waist Circumference (m) 96.9 ± 12.0 98.1 ± 19.5 0.579
Hip Circumference (m) 101.5 ± 12.9 103.4 ± 14.4 0.380
Waist Hip Ratio 0.96 ± 0.11 0.96 ± 0.08 0.882
Uric Acid (mmol/L) 7.2 ± 3.0 8.6 ± 4.4 0.017
Total cholesterol (mmol/L) 5.7 ± 1.5 6.9 ± 1.1 0.001
HDL-Cholesterol (mmol/L) 0.95 ± 0.23 0.89 ± 0.13 0.040
Triglyceride (mmol/L) 2.1 ± (1.0) 2.7 ± 0.9 0.001
Low Density Lipoprotein (mmol/L) 2.7 ± 1.0 3.4 ± 0.8 0.001
C-Reactive Protein (g/L) 7.5 ± 2.7 9.2 ± 2.2 0.001
Retinopathy (II-IV) Frequency% 34 (58.6 %) 63 (42.3 %) 0.0316
eGFR by MDRD (ml/min/1.73) 58.8 ± 28.9 50.3 ± 19.2 0.021
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and a major cause of cardiovascular events. This prospect-
ive cross sectional study evaluated common complications
of the eye and the kidneys among hypertensive individuals.
The prevalence of hypertensive retinopathy among the
study participants was 78 %. This prevalence is compar-
able with that of Ladipo [8] who reported a prevalence of
over 70 % among Nigeria hypertensive patients. Our result
is also similar to prevalence of retinopathy reported
among black hypertensive patients in other African coun-
tries [9, 12, 13], but higher than results among hyperten-
sive patients in Europe [14] and blacks in United States of
America [15]. On the other hand, our finding contrasts
that of Akinkugbe [7] who reported that hypertensive ret-
inopathy was a rare occurrence among African patients.
Perhaps, patients’ selection and sample size may account
for this difference as Akinkugbe’s study was limited by
small sample size and heterogeneous nature of his sample
population. Complications of hypertension such as LVH,
stroke and kidney failure have been reported to be com-
moner among Blacks than the Whites; and retinal changes
may not be an exception as shown in our study. The high
prevalence of retinopathy (an indication of changes in the
cerebral arteries) among study participants may also ex-
plain why there is high prevalence of stroke in our hyper-
tensive population [16].
Patients who had retinopathy are older than those with
normal retinal examination and positive correlation was
observed between age and retinopathy. Age has been
demonstrated as an independent predictor of retinopathy
in patients with hypertension in other studies [17, 18].
Age together with other factors such as duration of hyper-
tension, BMI, total cholesterol, LDL-c and C-reactive pro-
tein correlated with retinal changes in our patients. The
clustering of cardiovascular risk factors in the patients
studied could account for high prevalence of hypertensive
retinopathy.
Blood pressure indices (systolic and diastolic blood
pressures) have been found to be associated with risk of
development of hypertensive retinal changes [19, 20].
This is because hypertensive retinopathy is a reflection
of severity of blood pressure elevation and control over
a period of time. However, systolic and diastolic blood
pressures were similar between patients with retinopathy
and those without in our study.
Analysis of renal function among the study partici-
pants showed that eGFR was lower (46.2 ml/min/1.73)
in those with retinopathy than those without (55.9 ml/
min/1.73), p = 0.019. Similarly, a significant negative cor-
relation was observed between the presence of retinop-
athy and eGFR (R = −0.26, P = 0.001). These results show
that a significant number of our hypertensive patients
had reduction in their renal function and this may occur
simultaneous with other end organ consequence of the
disease including retinal changes. In addition, ACR
showed that a significant number of the patients studied
had albuminuria which is an indication of glomerular
dysfunction [21]. When patients with ACR ≤ 300 mg/g
were compared with those with ACR >300 mg/g, the lat-
ter have higher percentage of grades II-IV retinopathy,
higher levels of serum uric acid, C-reactive protein and
dyslipidaemia than the former. This is an indication of a
more severe disease among those with ACR > 300 mg/g
than those with ACR ≤300 mg/g. Elevated serum uric
acid level is associated with increased risk of chronic
kidney disease [22]. Long standing hypertension is asso-
ciated with vascular changes (arteriosclerosis) which
occur in all organs of the body including the eyes.
Therefore, the presence of hypertensive retinopathy
Table 4 Association of retinopathy with clinical and laboratory
characteristics
Characteristic Correlation coefficient P value
Age (years) 0.41 0.001
Duration of hypertension (years) 0.29 0.001
Body Mass Index (Kg/m2) 0.16 0.017
Systolic Blood pressure (mmHg) 0.07 0.295
Diastolic Blood Pressure (mmHg) −0.05 0.946
Mean Blood Pressure(mmHg) −0.03 0.637
Pulse Pressure (mmHg) 0.10 0.145
Waist Circumference (m) 0.09 0.200
Hip Circumference (m) 0.04 0.574
Waist Hip Ratio 0.08 0.226
Uric Acid (mmol/L) −0.001 0.990
Total cholesterol (mmol/L) 0.22 0.002
HDL-Cholesterol (mmol/L) −0.01 0.885
Low Density Lipoprotein (mmol/L) 0.23 0.001
Triglyceride (mmol/L) 0.11 0.111
Albumin-Creatinine Ratio (mg/g) 0.002 0.974
C-Reactive Protein (g/L) 0.17 0.016
eGFR by MDRD (ml/min/1.73) −0.26 0.001
Table 5 Multi-variable adjusted odds ratio for probability of
retinopathy
Variables Odd Ratio 95 % CI P-value
Age 1.08 1.044–1.127 0.001*
DOH 1. 05 0.996–1.115 0.067
BMI 1.20 1.040–1.389 0.013*
SBP 1.01 0.987–1.031 0.448
DBP 1.02 0.984–1.055 0.300
ACR 1.00 1.000–1.002 0.211
eGFR 1.00 0.969–1.005 0.146
Key: CI confidence interval, DOH duration of hypertension, BMI body mass
index, SBP systolic blood pressure, DBP diastolic blood pressure, ACR albumin
creatinine ratio, estimated glomerular filtration rate
*statistically significant
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detected at fundoscopy may be an indication for a more
extensive evaluation of function of other target organs in
hypertension such as the kidneys [23].
Multi-variable adjusted odds ratios showed increased
probability of retinopathy with age (odds ratio-1.08, p =
0.001) and body mass index (odds ratio-1.20, p = 0.013).
Obesity is considered to be a major cardiovascular risk
factor and microalbuminuria is an indication of renal
disease. Indeed, retinopathy, LVH and microalbuminuria
are considered as evidence of target organ damage in
systemic hypertension. Our study further confirmed the
beneficial role of ACEIs in the management of systemic
hypertension [24]. It is worthy of note that patients on
drug combinations including ACEIs had lower ACR
compared with those not on this drug. ACEIs protect
the kidneys and can prevent or delay onset of protein-
uria in kidney disease.
This study was limited by over representation of
women in our study participants which is a reflection of
health seeking behaviours among hypertensive patients
seen in our practice. Therefore, it may be difficult to
generalize our result to our population. Secondly, direct
ophalmoscopy was employed in the assessment of the
retina in our patients. Although, this is not inferior to
retinal photographs but might have provided opportun-
ity for further reviews.
Conclusion
Hypertensive retinopathy is a common clinical finding
among hypertensive Nigerians and occurs pari passu
with renal damage as consequences of long standing
hypertension. The presence of hypertensive retinopathy
may be an indication for further assessment of affected
individual especially the renal function.
Abbreviations
ACEI: Angiotensin converting enzyme inhibitor; ACR: Albumin creatinine
ratio; BMI: Body mass index; eGFR: Estimated glomerular filtration rate;
HDL-c: High density lipoprotein cholesterol; JNC: Joint National
Committee; LDL-c: Low density lipoprotein cholesterol; LVH: Left
ventricular hypertrophy; MDRD: Modification of diet in renal disease;
MOPD: Medical out-patient department
Acknowledgements
The authors are grateful to the clinic nurses, interns and resident doctors of the
Cardiology Unit who participated actively in the recruitment of the patients.
Funding
This study was funded by the Senate Research Grant (Faculty based), of
University of Ilorin. The funder had no role in the study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Availability of data and materials
Although the study is not a clinical trial or genetic study, the materials not
included as part of the data are available.
Authors’ contributions
Prof ABO conceived the idea of the study, was involved in the study design
and data interpretation. Dr PMK was involved in the design of the work,
acquisition and analysis of data; drafting of the manuscript. Dr TOO was
involved in study design, initial literature search, data analysis and
interpretation while Professor JFO and Dr VAO were part of the design,
ophthalmological data acquisition and interpretation of results. Similarly,
Dr SAB was involved in the study design, laboratory analysis and data
interpretation. All authors reviewed and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Although the manuscript does not involve the use of live photograph of any
of the participants, consent was obtained from them for the data to be
published as at the time recruitment into the study.
Ethics approval and consent to participate
Ethical approval was obtained from the Ethics and Research Committee of
our hospital. Verbal and written well informed consent was obtained from all
participants before they were eligible for recruitment into the study.
Author details
1Department of Medicine, University of Ilorin, P.M.B. 1515, Ilorin, Nigeria.
2Department of Ophthalmology, University of Ilorin, P.M.B. 1515, Ilorin,
Nigeria. 3Department of Chemical Pathology, University of Ilorin, P.M.B. 1515,
Ilorin, Nigeria. 4Department of Ophthalmology, University of Ilorin Teaching
Hospital, P.M.B. 1459, Ilorin, Nigeria.
Received: 15 May 2016 Accepted: 10 October 2016
References
1. Joffres M, Falascheetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, et al.
Hypertension prevalence, awareness, treatment and control in national
surveys from England, the USA and Canada, and correlation with stroke and
ischemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3:
e003423. Available at: http://bmjopen.bmj.com/content/3/8/e003423.abstract.
2. Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry
respond better to calcium blockers and diuretics than to ACE inhibitors and
B-adrenergic blockers? A systematic review. BMC Med. 2013;11:141.
Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681568/.
3. Wong TY, Klein R, Klein BEK, Tielsch JM, Mat LH, Nieto FJ. Retinal
microvascular abnormalities and their relationship with hypertension,
cardiovascular disease and mortality. Surv Ophthalmol. 2001;46(1):59–80.
Available at: http://www.ncbi.nlm.nih.gov/pubmed/11525792.
4. Klein R, Klein BEK, Moss SE, Wang Q. Hypertension and retinopathy,
arteriolar narrowing and arteriovenous nicking in a population. Arc
Ophthalmol. 1994;112:92–8. Available at: http://www.ncbi.nlm.nih.gov/
pubmed/8285901.
5. Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, et al.
Retinal microvascular abnormalities and incident stroke: the atherosclerosis
risk in communities study. Lancet. 2001;358:1134–40. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/11597667.
6. The Sixth Report of the Joint National Committee on Prevention, detection,
evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;
157:2413-2446. [Erratum, Arch Intern Med. 1998;158:573]. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/9385294.
7. Akinkugbe OO. The rarity of hypertensive retinopathy in the African. Am J
Med. 1968;45:401–4. Available at: http://www.sciencedirect.com/science/
article/pii/0002934368900740.
8. Ladipo GOA. Hypertensive retinopathy in Nigerians: a prospective
clinical study of 350 cases. Trop Geogr Med. 1981;33:311–6. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/7342375.
9. Kabedi NN, Mwanza J, Lepira FB, Kayembe TK, Kayembe DL. Hypertensive
retinopathy and its association with cardiovascular, renal and
cerebrovascular morbidity and mortality in Congolese patients. Cardiovasc
J Afr. 2014;25(5):228–32. Available at: http://www.ncbi.nlm.nih.gov/pmc/
articles/PMC4241591/.
10. Carpinella G, Pagano G, Buono F, Petitto M, Guarino G, Orefice G, et al.
Prognostic value of combined target-organ damage in patients with
essential hypertension. Am J Hypertens. 2015;28(1):127–34. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/24936579.
Omotoso et al. Clinical Hypertension  (2016) 22:19 Page 6 of 7
11. Chobanian AV, Bakris GL, Black BK, Cushman WC, Green LA, Izzo JL, et al.
The National High Blood Pressure Education Program Coordinating
Committee. Seventh report of the Joint National Committee on prevention,
detection, evaluation, and treatment of high blood pressure. Hypertens.
2003;42:1206–52. Available at: http://www.nhlbi.nih.gov/files/docs/
guidelines/jnc7full.pdf.
12. Okpechi I, Oluleye TS, Bekibele CO, Adedapo KS, Adebiyi AA, Ogah OS, et al.
Unexpectedly high prevalence of target-organ damage in newly diagnosed
Nigerians with hypertension: cardiovascular topic. Cardiovasc J Afr. 2007;
18(2):77–83. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17497043.
13. Choi Y. The incidence and associated factors of hypertensive retinopathy
among hypertensive patients attending Mulago Hospital. Makerere University
Institutional Repository. 2005: Available at: http://makir.mak.ac.ug/handle/
10570/1593. Accessed 17 Oct 2016.
14. Erden S, Bicakci E. Hypertensive retinopathy: incidence, risk factors, and
comorbidities. Clin Exp Hypertens. 2012;34(6):397–401. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/22468968.
15. Wong TY, Klein R, Duncan BB, Nieto FJ, Klein BEK, Couper DJ, et al. Racial
differences in the prevalence of hypertensive retinopathy. Hypertens. 2003;
41:1086–91. Available at: http://hyper.ahajournals.org/content/41/5/1086.full.
16. Ong YT, Wong TY, Klein R, Klein BE, Mitchell P, Sharrett AR, et al.
Hypertensive retinopathy and risk of stroke. Hypertens. 2013;62(4):706–11.
Available at: http://www.ncbi.nlm.nih.gov/pubmed/23940194.
17. Kim GH, Youn HJ, Kang S, Choi YS, Moon JI. Relation between grade II
hypertensive retinopathy and coronary artery disease in treated essential
hypertensives. Clin Exp Hypertens. 2010;32(7):469-473. Available at: http://
www.tandfonline.com/doi/full/10.3109/10641963.2010.496515?src=recsys.
18. Addo J, Smeeth L, Leon DA. Hypertensive target organ damage in
Ghanaians civil servants with hypertension. PLoS One. 2009;4(8):e6672.
Available at: http://www.ncbi.nlm.nih.gov/pubmed/19701488.
19. Gallego PH, Maria E, Craig ME, Hing S, Donaghue KC. Role of blood pressure
in development of early retinopathy in adolescents with type 1 diabetes:
prospective cohort study. BMJ. 2008;337:a918. Available at: http://www.bmj.
com/content/337/bmj.a918.
20. Chatterjee S, Chattopadhya S, Hope-Ross M, Lip PL. Hypertension and the
eye: changing perspectives. J Hum Hypertens. 2002;16:667–75. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/12420190.
21. Yip W, Sabanayagam C, Teo BW, Tay WT, Ikram MK, Tai ES, et al. Retinal
microvascular abnormalities and risk of renal failure in Asian populations.
PLoS One. 2015;10(2):e0118076. Available at : http://journals.plos.org/
plosone/article?id=10.1371/journal.pone.0118076.
22. Johnson RJ, Nakagawa T, Jalal D, Sánchez-Lozada LG, Kang D, Ritz E. Uric
acid and chronic kidney disease: which is chasing which? Nephrol Dial
Transplant. 2013;28(9):2221–8. Available at: http://www.ncbi.nlm.nih.gov/
pubmed/23543594.
23. Grunwald JE, Alexander J, Ying GS, Maguire MG, Daniel E, Whittock-Martin R,
et al. Retinopathy and chronic kidney disease in the Chronic Renal
Insufficiency Cohort (CRIC) Study. Arch Ophthalmol. 2012;130(9):1136–44.
Availabble at: http://www.ncbi.nlm.nih.gov/pubmed/22965589.
24. Baltatzi M, Savopoulos CH, Hatzitolios A. Role of angiotensin converting
enzyme inhibitors and angiotensin receptor blockers in hypertension of
chronic kidney disease and renoprotection. Study results. Hippokratia. 2011;
15 Suppl 1:27–32. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/
PMC3139675/.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Omotoso et al. Clinical Hypertension  (2016) 22:19 Page 7 of 7
